Keyphrases
Angiogenesis Inhibition
100%
Antiangiogenic Activity
100%
Levamisole
100%
N-alkylated
100%
Chemotype
66%
Angiogenesis Inhibitors
66%
Antibody Treatment
33%
Angiogenesis in Vitro
33%
Suramin
33%
Structure-activity Relationship
33%
Treatment Strategy
33%
Skin Fibroblasts
33%
In Vitro Evaluation
33%
Tumor Inhibition
33%
Cord-like
33%
Parent Compounds
33%
Anthelminthic Drugs
33%
Aniline
33%
Low Molecular Weight
33%
Thrombosis
33%
Human Use
33%
Mechanism of Action
33%
Human Umbilical Vein Endothelial Cells (HUVECs)
33%
Monoclonal Antibody
33%
Cancer Treatment
33%
Clinical Profile
33%
Vascular Endothelial Growth Factor
33%
Immunology and Microbiology
Levamisole
100%
Antiangiogenic Activity
100%
Chemotype
33%
Vasculotropin
16%
Molecular Weight
16%
Angiogenesis Inhibitor
16%
Coculture
16%
Neutralization
16%
Angiogenesis
16%
Fibroblast
16%
Structure Activity Relation
16%
Normal Human
16%
Monoclonal Antibody
16%
Growth Inhibition
16%
Umbilical Vein Endothelial Cell
16%
Pharmacology, Toxicology and Pharmaceutical Science
Antiangiogenic
100%
Levamisole
100%
Side Effect
40%
Vasculotropin
20%
Monoclonal Antibody
20%
Thrombosis
20%
Suramin
20%
Angiogenesis Inhibitor
20%
Cancer Inhibition
20%
Malignant Neoplasm
20%
Structure Activity Relationship
20%
Normal Human
20%
Medicine and Dentistry
Levamisole
100%
Suramin
16%
Human Umbilical Vein Endothelial Cell
16%